APNA CLINICAL PSYCHOPHARMACOLOGY INSTITUTE
VIRTUAL PROGRAM

Engaging Pharmacotherapeutic Nursing Partnerships

Registration is now Closed
Session recordings from this year's program will be available in the APNA eLearning Center in the coming weeks!
 

Women listening to a presentation at the Clinical Psychopharmacology Institute

Thursday, June 11

 

3.5 Contact Hours

 

1:30pm - 2:30pm Eastern
12:30pm Central | 10:30am Pacific

Online Attendee Networking Chat & Virtual Exhibit Hall Open


2:30pm - 4:30pm Eastern
1:30pm Central | 11:30am Pacific

2.0 Contact Hours
 


PRE-CONFERENCE COURSE*:  Turning Down the Heat: Psychopharmacologic Management of Irritability through Aggression
Julie A. Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APN – Register for this pre-conference course to discuss the psychopharmacology and utility of agents used for the management of irritability through aggression. Strategies from this course can be applied across diagnoses and for both acute and outpatient settings.Register for this pre-conference course to explore neurotransmitters, particularly glutamate and GABA, from a psychopharmacological perspective. You’ll also leave this course with a better understanding of how this neurobiology relates to the lived experience of persons with mental health disorders. *Thursday night Pre-Conference sessions are not included in the conference registration rate. To attend this session and earn 2.0 contact hours, select the pre-conference during registration. An additional cost will apply.


4:30pm - 5:00pm Eastern
3:30pm Central | 1:30pm Pacific


CPI Kickoff
Online Attendee Networking Chat & Virtual Exhibit Hall Open
 


5:00pm - 6:40pm Eastern
4:00pm Central | 2:00pm Pacific

1.5 Contact Hours


Care Considerations for Ketamine and Esketamine Treatment
Paula Bolton, MS, CNP, ANP-BC

Examine ketamine's potential use for treatment-resistant psychiatric disorders, including major depressive disorder, bipolar disorder, and post-traumatic stress disorder. Discuss best practices for incorporating esketamine to treat individuals with such disorders.


6:40pm - 7:40pm Eastern
5:40pm Central | 3:40pm Pacific


Product Theater: Management of TD
Richard Jackson, MD and David Hughes, NP

Sponsored by Teva Pharmaceuticals

 
Friday, June 12
6.75 Contact Hours


9:00am Eastern
8:00am Central | 6:00am Pacific


Online Attendee Networking Chat & Virtual Exhibit Hall Open


9:30am - 12:00pm Eastern
8:30am Central | 6:30am Pacific

2.25 Contact Hours


KEYNOTE: The Medication Interest Model (MIM): A Transformative Shared Decision Making Model
Shawn Christopher Shea, M.D.

A clinical interviewing approach for simultaneously forging the therapeutic alliance while enhancing medication understanding, interest, and follow-through. Over 100 easily learned and easily taught techniques for talking with patients about medications from initially describing one’s approach to prescribing medications to uncovering a patient’s true concerns about side effects to enhancing medication adherence through the use of a new motivational theory (the Choice Triad).


12:10pm - 1:40pm Eastern
11:10am Central | 9:10am Pacific

1.5 Contact Hours


The Psychosocial Dimension of Psychopharmacology
David Mintz, MD

Explore common dynamics that can fuel treatment resistance, the evidence base regarding psychosocial aspects of pharmacotherapy - including elements of an effective and patient-centered alliance - and consider the role of the person as prescriber in fostering good outcomes.


1:40pm - 2:10pm Eastern
12:40pm Central | 10:40am Pacific


Break
Online Attendee Networking Chat & Virtual Exhibit Hall Open


2:10pm - 3:10pm Eastern
1:10pm Central | 11:10am Pacific

1.0 Contact Hours


Symposium: Clinical Convergence®: A Patient-Centered Approach to Child and Adolescent Bipolar Depression
Sara Jones, PhD, RN, APRN, PMHNP-BC and Robert A. Kowatch, MD, PhD

This virtual symposium will provide attendees with guidance on how to readily identify, diagnose, and effectively manage bipolar depression in pediatric patients. The expert panel will be joined by surprise panelists who will provide deeper insights into patients’ experiences.

This activity is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC, and is supported by an independent education grant from Sunovion Pharmaceuticals Inc.


3:20pm - 3:50pm Eastern
2:20pm Central | 12:20pm Pacific

0.5 Contact Hours


PANEL DISCUSSION: Clinical Practice during COVID-19
CPI Program Committee

Gain an understanding of how the COVID-19 pandemic has impacted clinical practice, how to better serve patients during this time, and how to anticipate and prepare for its longer term impacts.


4:00pm - 5:30pm Eastern
3:00pm Central | 1:00pm Pacific

1.5 Contact Hours


Can We Medicate Suicidal Ideation? Pharmacotherapeutics of Suicide
Barbara J. Limandri, PhD, PMHCNS-BC

Explore pharmacotherapeutic interventions for suicidal ideation and behavior. Incorporate psychosocial and neurobiological aspects of suicide to create a cohesive intervention strategy for suicide prevention.


5:30pm - 6:30pm Eastern
4:30pm Central | 2:30pm Pacific


Product Theater: Discover an Effective LAI Treatment for Schizophrenia in Adults
Jeremy Schreiber, APRN, PMHNP-BC

Sponsored by Alkermes

 
Saturday, June 13
6.0 Contact Hours


9:00am Eastern
8:00am Central | 6:00am Pacific


Online Attendee Networking Chat & Virtual Exhibit Hall Open


10:00am - 11:30am Eastern
9:00am Central | 7:00am Pacific

1.5 Contact Hours


KEYNOTE: Improving Patient Outcomes in Schizophrenia
Christoph U. Correll, MD

Review the evidence on best approaches for caring for individuals with schizophrenia, including acute, mid-, and long-term therapy options. Understand the risks, benefits, and effectiveness of psychopharmacologic interventions for schizophrenia.


11:40am - 1:10pm Eastern
10:40am Central | 8:40am Pacific

1.5 Contact Hours


Perinatal Mood and Anxiety Disorders: Walking the Tightrope of Care
Kathryn S. Johnson, MSN, PMHCNS-BC, PMHNP-BC

This presentation will discuss the assessment and management of mood and anxiety symptoms throughout pregnancy and for the first year after birth.


1:10pm - 2:10pm Eastern
12:10pm Central | 10:10am Pacific


Product Theater: Keep the Body in Mind: Looking at the Pathophysiology and Comorbidities Associated with Bipolar Disorder or Schizophrenia
Dawn I. Velligan, PhD

Sponsored by Alkermes


2:10pm - 2:40pm Eastern
1:10pm Central | 11:10am Pacific


Break
Online Attendee Networking Chat & Virtual Exhibit Hall Open


2:40pm - 4:20pm Eastern
1:40pm Central | 11:40am Pacific

1.5 Contact Hours


Drug Interactions: Psychotropic Medications, Supplements, & Herbal Products
Mary Gutierrez, PharmD, BCPP

Identify strategies to minimize or avoid psychotropic drug interactions with prescription medications, supplements, and herbal products. Determine potential impact of adding these products to an existing drug regimen.


4:20pm - 5:40pm Eastern
3:20pm Central | 1:20pm Pacific

1.5 Contact Hours


Recognition, Assessment & Treatment of Movement Disorders
Rebecca S. Roma, MD, MBA

Analyze different presentations of drug induced movement disorders and look at treatment options including dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia.

Sunday, June 14
5.75 Contact Hours

 

9:00am Eastern
8:00am Central | 6:00am Pacific

Online Attendee Networking Chat & Virtual Exhibit Hall Open


10:00am - 11:30am Eastern
9:00am Central | 7:00am Pacific

1.5 Contact Hours


PTSD, Military, Aggression, Depression, Military Culture
CDR Joseph Holshoe, PMHNP-BC

Discuss unique concerns of individuals in the military regarding pharmacology, mental health treatment, and diagnoses. Differentiate between mental health disorder symptoms in individuals in the military and civilians.


11:40am - 1:10pm Eastern
10:40am Central | 8:40am Pacific

1.5 Contact Hours


Pharmacogenomics: Understanding the Science and Applications to Patient Care
Jeffrey Bishop, PharmD, MS, BCPP, FCCP

Uncover the science and clinical implications of pharmacogenomic testing, regulatory considerations, and guidelines evaluating evidence for clinical utility. Understand the current limitations of pharmacogenomic testing in mental health and discover resources to advance knowledge.


1:10pm - 1:40pm Eastern
12:10pm Central | 10:10am Pacific


Break
Online Attendee Networking Chat & Virtual Exhibit Hall Open


1:40pm - 3:00pm Eastern
12:40pm Central | 10:40am Pacific

1.5 Contact Hours


Fact or Fiction: Psychopharmacology of Anxiety Disorders
Jeffrey R. Strawn, MD, FAACAP

Review and summarize new data regarding psychopharmacology for anxiety disorders from childhood and adolescence to older adults. Focus on comparative efficacy and tolerability of treatments and on strategies for managing common side effects and common clinical challenges of treating anxiety disorders.


3:20pm - 4:50pm Eastern
2:20pm Central | 12:20pm Pacific

1.25 Contact Hours


Best Practices for Serving and Supporting Gender Diverse Patients
Rhonda Schwindt, DNP, PMHNP-BC

Examine best practices for pharmacological and non-pharmacological interventions for gender- diverse patients and discuss strategies to reduce barriers to affirmative mental health care.

On-Demand
1.75 Contact Hours

 

On-Demand in the APNA eLearning Center

Getting Unstuck - The Future of Psychedelic-Assisted Therapy
Andrew Penn, RN, MS, CNS, PMHNP-BC

Gain an understanding of the history of psychedelic agents in psychiatry, and how contemporary research represents a continuation of past research using them to assist therapy in the treatment of mental illness.

As part of your registration package, enjoy this brand new webinar in the APNA eLearning Center. This is in addition to the access to recordings of the sessions presented Thursday – Sunday.


 


CPI provides up to 23.75 total contact hours, including the pre-conference.

 

Program is subject to change.  Please continue to check this page for updates.
The content of this Nursing Continuing Professional Development activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.

The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


*Pre-Conference Session: Select the pre-conference session add-on during registration (additional fee) to earn up to an additional 2 contact hrs. Available in additional to full or one day conference registrations

AMERICAN PSYCHIATRIC NURSES ASSOCIATION and APNA-Logoare registered in the U.S. Patent and Trademark Office as trademarks of the American Psychiatric Nurses Association.
The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.